Jubilant Life Q4 net up 65% to Rs 70.68 crore

NEW DELHI: Jubilant Life Sciences on Tuesday reported a 65.41% rise in consolidated net profit to Rs 70.68 crore during JanuaryMarch against a year ago. “We have

Published on: May 25, 2016, 08:27:26 IST

By Anonymous

Prefer HTon Google

Share via

Copy link

NEW DELHI: Jubilant Life Sciences on Tuesday reported a 65.41% rise in consolidated net profit to Rs 70.68 crore during JanuaryMarch against a year ago. “We have delivered strong and consistent performance through the year thereby achieving our highest-ever EBITDA of Rs 1,291 crore in 2015-16,” said Shyam S Bhartia, chairman, and Hari S Bhartia, co-chairman and MD, Jubilant Life Sciences. The growth has been led by the company’s pharmaceuticals segment, specifically its speciality pharmaceuticals (sterile products) business.

Stay updated with the latest Business News on Petrol Price, Gold Rate, Silver Rates, Diesel Prices along with Income Tax Calculator